BioCentury
ARTICLE | Financial News

Melinta raises $110M in follow-on

May 24, 2018 5:14 PM UTC

Anti-infectives company Melinta Therapeutics Inc. (NASDAQ:MLNT) raised $110 million through the sale of 22 million shares at $5 in a follow-on underwritten by J.P. Morgan, Jefferies and Cantor Fitzgerald. The price is a 32% discount to Melinta's closing price of $7.30 on Monday, when the company proposed after market hours to raise $75 million.

Melinta slipped 11% to $6.50 on Tuesday. It was down $0.92 (15%) to $5.30 on Thursday, and has lost $2 (27%) since Monday's close...

BCIQ Company Profiles

Melinta Therapeutics LLC